Maximally tolerated guideline-directed medical therapy and barriers to optimization in patients with heart failure with reduced ejection fraction: The COAPT trial
28 August 2022 (15:15 - 16:00)
Organised by:
Abstract
Slides
About the speaker
Lipscomb University College of Pharmacy, Nashville (United States of America)
6 More presentations in this session
Miss C. Garred (Herlev, DK)
Doctor K. Odegaard (Oslo, NO)
Access the full session
The Event
ESC Congress 2022
28 August 2022
15:15 CET
You may be interested in
Congress Presentation
